Resonance Health Limited (ASX:RHT)
Australia
· Delayed Price · Currency is AUD 0.0400
0.00 (0.00%)
Apr 24, 2025, 12:14 PM AEST
Resonance Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | 10.53 | 8.59 | 4.4 | 3.83 | 3.78 | 3.67 | Upgrade
|
| Other Revenue | - | - | - | 0.03 | - | - | Upgrade
|
| Revenue | 10.53 | 8.59 | 4.4 | 3.85 | 3.78 | 3.67 | Upgrade
|
| Revenue Growth (YoY) | 89.13% | 95.02% | 14.31% | 1.96% | 3.02% | 1.20% | Upgrade
|
| Gross Profit | 10.53 | 8.59 | 4.4 | 3.85 | 3.78 | 3.67 | Upgrade
|
| Selling, General & Admin | 9.62 | 7.16 | 4.19 | 3.76 | 2.38 | 3.92 | Upgrade
|
| Research & Development | 0.82 | 0.84 | 0.71 | 0.72 | 0.39 | 0.15 | Upgrade
|
| Other Operating Expenses | 0.96 | 0.67 | 0.43 | 0.47 | 0.24 | 0.22 | Upgrade
|
| Operating Expenses | 11.82 | 9.17 | 5.76 | 5.38 | 3.38 | 4.63 | Upgrade
|
| Operating Income | -1.29 | -0.58 | -1.36 | -1.52 | 0.4 | -0.96 | Upgrade
|
| Interest & Investment Income | 0.11 | 0.14 | 0.04 | 0 | 0.04 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.07 | 0.04 | 0.29 | 0.19 | -0.09 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.32 | -0.23 | -0.2 | -0.22 | -0.01 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | -1.58 | -0.63 | -1.23 | -1.55 | 0.34 | -0.95 | Upgrade
|
| Asset Writedown | - | - | -0.03 | - | - | - | Upgrade
|
| Pretax Income | -1.58 | -0.63 | -1.26 | -1.55 | 0.34 | -0.95 | Upgrade
|
| Income Tax Expense | -1.27 | -0.8 | -0.48 | -0.41 | -0.24 | -0.24 | Upgrade
|
| Net Income | -0.31 | 0.17 | -0.78 | -1.14 | 0.59 | -0.72 | Upgrade
|
| Net Income to Common | -0.31 | 0.17 | -0.78 | -1.14 | 0.59 | -0.72 | Upgrade
|
| Shares Outstanding (Basic) | 449 | 456 | 461 | 461 | 450 | 432 | Upgrade
|
| Shares Outstanding (Diluted) | 449 | 468 | 461 | 461 | 452 | 432 | Upgrade
|
| Shares Change (YoY) | 1.66% | 1.59% | - | 1.97% | 4.59% | 6.52% | Upgrade
|
| EPS (Basic) | -0.00 | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 | Upgrade
|
| Free Cash Flow | 2.41 | 1.16 | -0.45 | -1.57 | 1.13 | 1.31 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -12.22% | -6.71% | -30.89% | -39.57% | 10.58% | -26.28% | Upgrade
|
| Profit Margin | -2.94% | 1.97% | -17.72% | -29.63% | 15.50% | -19.49% | Upgrade
|
| Free Cash Flow Margin | 22.85% | 13.48% | -10.11% | -40.86% | 29.86% | 35.68% | Upgrade
|
| EBITDA | -1.2 | -0.46 | -1.32 | -1.49 | 0.42 | -0.94 | Upgrade
|
| EBITDA Margin | -11.36% | -5.32% | -29.96% | -38.69% | 11.09% | -25.75% | Upgrade
|
| D&A For EBITDA | 0.09 | 0.12 | 0.04 | 0.03 | 0.02 | 0.02 | Upgrade
|
| EBIT | -1.29 | -0.58 | -1.36 | -1.52 | 0.4 | -0.96 | Upgrade
|
| EBIT Margin | -12.22% | -6.71% | -30.89% | -39.57% | 10.58% | -26.28% | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.